MedPath

Jubilant Draximage Inc

🇨🇦Canada
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

12

FDA:10
CANADA:1

Drug Approvals

DRAXIMAGE MAA

Approval Date
Feb 13, 2024
FDA

Fludeoxyglucose F 18

Approval Date
Jan 10, 2024
FDA

Kit for the Preparation of Technetium Tc 99m Sulfur Colloid

Approval Date
Dec 5, 2023
FDA

DRAXIMAGE DTPA

Approval Date
May 8, 2023
FDA

TECHNETIUM Tc 99m MERTIATIDE

Approval Date
Jan 22, 2023
FDA

Drax Exametazime

Approval Date
Nov 8, 2022
FDA

HICON

Approval Date
May 17, 2022
FDA

RUBY-FILL

Approval Date
Oct 20, 2020
FDA

Sodium Iodide I 131 Diagnostic

Approval Date
Aug 25, 2020
FDA

Technetium Tc 99m Medronate

Approval Date
Aug 25, 2020
FDA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.